|By PR Newswire||
|March 28, 2014 10:04 AM EDT||
DUBLIN, Mar. 28, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
As the air becomes more contaminated, incidence of asthma and chronic obstructive pulmonary diseases also increases. Consequently, more market space is provided for relevant drug manufacturers.
Asthma is a common multiple disease mainly caused by inheritance and environment factors. Recurrent attacks of asthma can lead to complications such as chronic obstructive pulmonary disease, emphysema, cor pulmonale, heart failure and respiratory failure. Sometimes it can endanger patients' lives.
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease that is not fully reversible. It includes chronic bronchitis and emphysema. Pathogens include smoking, air pollution, small airway infection and pneumoconiosis. There are approximately 600 million people worldwide suffering from chronic obstructive pulmonary diseases. According to WHO, COPD is the fourth biggest killer among diseases worldwide. It ranks the same with AIDS after heart diseases, cerebrovascular diseases and acute pulmonary infection. There are over 200 million COPD patients in the world now, and its mortality rate continues to rise year after year. More than 3 million people die of this disease every year with 1.2 million of them in China.
As patients of asthma and chronic obstructive pulmonary disease become more, demand of the medication worldwide also grows steeply. Developed by Boehringer Ingelheim Group with the trade name ""Spiriva"", tiotropium bromide was approved in the Netherlands and Philippines for the first time in June 2002. It was approved to China in 2006. Global sales revenue of Spiriva in 2012 was USD 4.71 billion, increased by 13% YOY.
According to CRI's market investigation, the CAGR of sales revenue of tiotropium bromide in China sample hospital market is more than 70% from 2007 to 2012. Most market share was seized by Boehringer Ingelheim Group followed by Chia Tai Tianqing Pharmaceutical, which totally added up to over 90% of the market. Besides Spiriva from Boehringer Ingelheim Group, four Chinese pharmaceutical manufacturers have received production approval.
Industrial development and lack of environmental concern have led to serious air contamination in China. Incidence of COPD in China is predicted to keep increasing, leading to increasing demand of relevant medication. Anticipation shows that market size of tiotropium bromide in China will keep expanding rapidly in the next few years.
Key Topics Covered:
1 Relevant Concepts of Tiotropium Bromide
2 Market Overview of Tiotropium Bromide in China, 2009-2013
3 Investigation on Sales Value of Tiotropium Bromide in China, 2009-2013
4 Investigation on Market Share of Major Tiotropium Bromide Manufacturers in China, 2009-2013
5 Investigation on Market Size of Tiotropium Bromide by Dosage Form in China, 2009-2013
6 Reference Price of Tiotropium Bromide Produced by Different Enterprises in China Hospital Market
7 Major Manufacturing Enterprises in China Tiotropium Bromide Market, 2009-2014
8 Prospect of China Tiotropium Bromide Market, 2014-2018
- Boehringer Ingelheim
- Chia Tai Tianqing Pharmaceutical Group
- Zhejiang Xianju Pharmaceutical
For more information visit http://www.researchandmarkets.com/research/8gxjqj/investigation
Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Oct. 25, 2016 11:42 AM EDT
Oct. 25, 2016 11:30 AM EDT Reads: 2,001
Oct. 25, 2016 11:30 AM EDT Reads: 1,105
Oct. 25, 2016 11:30 AM EDT Reads: 3,593
Oct. 25, 2016 11:15 AM EDT Reads: 1,514
Oct. 25, 2016 11:15 AM EDT Reads: 3,640
Oct. 25, 2016 11:15 AM EDT Reads: 3,913
Oct. 25, 2016 11:00 AM EDT Reads: 3,669
Oct. 25, 2016 11:00 AM EDT Reads: 4,530
P2P RTC will impact the landscape of communications, shifting from traditional telephony style communications models to OTT (Over-The-Top) cloud assisted & PaaS (Platform as a Service) communication services. The P2P shift will impact many areas of our lives, from mobile communication, human interactive web services, RTC and telephony infrastructure, user federation, security and privacy implications, business costs, and scalability. In his session at @ThingsExpo, Robin Raymond, Chief Architect...
Oct. 25, 2016 10:45 AM EDT Reads: 3,676
Oct. 25, 2016 10:45 AM EDT Reads: 3,060
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of So...
Oct. 25, 2016 10:45 AM EDT Reads: 2,172
SYS-CON Events announced today that Embotics, the cloud automation company, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Embotics is the cloud automation company for IT organizations and service providers that need to improve provisioning or enable self-service capabilities. With a relentless focus on delivering a premier user experience and unmatched customer support, Embotics is the fas...
Oct. 25, 2016 10:45 AM EDT Reads: 911
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, will discuss how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team a...
Oct. 25, 2016 10:31 AM EDT Reads: 185
The Open Connectivity Foundation (OCF), sponsor of the IoTivity open source project, and AllSeen Alliance, which provides the AllJoyn® open source IoT framework, today announced that the two organizations’ boards have approved a merger under the OCF name and bylaws. This merger will advance interoperability between connected devices from both groups, enabling the full operating potential of IoT and representing a significant step towards a connected ecosystem.
Oct. 25, 2016 10:30 AM EDT Reads: 1,244